Literature DB >> 1289432

Purple glove syndrome: a complication of intravenous phenytoin.

D R Hanna1.   

Abstract

Intravenous phenytoin, available for use since 1956, has several well known adverse effects, such as hypotension, arrhythmias and toxicity. Purple glove syndrome is a less common complication that can have serious consequences. Fasciotomies, amputations and permanent disuse of the hand and forearm have been reported. The etiology of purple glove syndrome is still unknown, but possible etiologies and risk factors have been suggested. Three stages of purple glove syndrome have been identified: appearance, progression and resolution. During the second stage, progression, purple glove syndrome can be identified as either mild or severe. Mild cases may heal uneventfully when nursing measures such as elevation, application of dry, gentle heat and measures to prevent secondary injury are instituted. Severe cases may require emergency surgical intervention such as fasciotomy to relieve pressure and restore blood flow. Therapeutic nursing interventions aimed at maximizing healing and promoting comfort are essential.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1289432     DOI: 10.1097/01376517-199212000-00011

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN: 0888-0395            Impact factor:   1.230


  9 in total

1.  An atypical case of purple glove syndrome: an avoidable adverse event.

Authors:  Hanaa Rajabally; Sathiji Nageshwaran; Sabina Russell
Journal:  BMJ Case Rep       Date:  2012-07-09

2.  Phenytoin-Induced Purple Glove Syndrome: A Case Report and Review of the Literature.

Authors:  John I Okogbaa; IfeanyiChukwu O Onor; Oluwatoyin A Arije; Martha B Harris; Rebecca A Lillis
Journal:  Hosp Pharm       Date:  2015-05

3.  Purple glove syndrome: a dreadful complication of intravenous phenytoin administration.

Authors:  Rakesh Lalla; Hardeep Singh Malhotra; Ravindra Kumar Garg; Ritesh Sahu
Journal:  BMJ Case Rep       Date:  2012-08-24

Review 4.  Fosphenytoin and phenytoin in patients with status epilepticus: improved tolerability versus increased costs.

Authors:  J C DeToledo; R E Ramsay
Journal:  Drug Saf       Date:  2000-06       Impact factor: 5.606

Review 5.  Purple Glove Syndrome after Phenytoin or Fosphenytoin Administration: Review of Reported Cases and Recommendations for Prevention.

Authors:  Lyudmila A Garbovsky; Byron C Drumheller; Jeanmarie Perrone
Journal:  J Med Toxicol       Date:  2015-12

6.  Bioavailability of intravenous fosphenytoin sodium in healthy Japanese volunteers.

Authors:  Yushi Inoue; Naotaka Usui; Tadayuki Hiroki; Kenji Shimizu; Susumu Kobayashi; Shigeki Shimasaki
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-09-12       Impact factor: 2.441

7.  Purple glove syndrome: A looming threat.

Authors:  S Senthilkumaran; N Balamurgan; P Suresh; P Thirumalaikolundusubramanian
Journal:  J Neurosci Rural Pract       Date:  2010-07

8.  An anaesthesiologist's encounter with purple glove syndrome.

Authors:  B Uma; Anjali Kochhar
Journal:  Indian J Anaesth       Date:  2016-03

9.  Purple Glove Syndrome: Recognizing a Rare Complication of Intravenous Phenytoin.

Authors:  Genesis Perez Del Nogal; Alyssa Rodaniche; Sailaja Devi Saragadam
Journal:  Cureus       Date:  2022-04-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.